ETHYOL
Dead / Cancelled — Cancelled — Section 8 (as of 01 Feb 2013)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 76339868
- Registration number
- 2585403
- Mark type
- Design + words
- Filed
- 20 Nov 2001
- Published for opposition
- 02 Apr 2002
- Registered
- 25 Jun 2002
- Attorney of record
- Wm. Charles Saunders
Goods and services
- Class 005 — Pharmaceuticals: THERAPEUTIC DRUG ADMINISTERED IN CONNECTION WITH CHEMOTHERAPY OR RADIATION THERAPY IN THE TREATMENT OF CANCER
Owner
- CLINIGEN GROUP PLC, STAFFORDSHIRE, GB
- MEDIMMUNE, LLC, GAITHERSBURG, MD
- MedImmune Oncology, Inc., West Conshohocken, PA, US
- MedImmune Oncology, Inc., West Conshohocken, PA, US
- MedImmune Oncology, Inc., West Conshohocken, PA, US
Prior registrations
Prosecution history
- 22 Apr 2015 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 01 Feb 2013 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 06 Aug 2008 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 31 Jul 2008 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 02 Jul 2008 — ASSIGNED TO PARALEGAL
- 25 Jun 2008 — TEAS SECTION 8 & 15 RECEIVED
- 27 Mar 2008 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Mar 2008 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Oct 2007 — CASE FILE IN TICRS
- 01 Sept 2006 — REVIEW OF CORRESPONDENCE COMPLETE
- 21 Aug 2006 — PAPER RECEIVED
- 25 Jun 2002 — REGISTERED-PRINCIPAL REGISTER
- 02 Apr 2002 — PUBLISHED FOR OPPOSITION
- 13 Mar 2002 — NOTICE OF PUBLICATION
- 01 Feb 2002 — APPROVED FOR PUB - PRINCIPAL REGISTER